Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cnossen

Showing results (411-420 of 442) with videos related to

Pageof 45
Sort By:
Hemasphere|June 26, 2024
Metabolic blood profile and response to treatment with the pyruvate kinase activator mitapivat in patients with sickle cell diseaseMyrthe J van Dijk, Titine J J Ruiter, Sigrid van der Veen, et al.
Research and Practice in Thrombosis and Haemostasis|April 25, 2024
Tachyphylaxis and reproducibility of desmopressin response in perioperative persons with nonsevere hemophilia A: implications for clinical practiceL G R Romano, L M Schütte, R M van Hest, et al.
Thrombosis and Haemostasis|June 12, 2015
The "OPTI-CLOT" trial. A randomised controlled trial on periOperative PharmacokineTIc-guided dosing of CLOTting factor concentrate in haemophilia AHendrika C A M Hazendonk, Iris van Moort, Karin Fijnvandraat, et al.
Clinical and Translational Radiation Oncology|April 21, 2026
Outcomes after (chemo)radiotherapy for anal cancer - A nationwide cohort studyC L Deijen, M Berbée, E D Geijsen, et al.
Blood Advances|May 3, 2021
Molecular analysis of the erythroid phenotype of a patient with BCL11A haploinsufficiencyMarja W Wessels, Marjon H Cnossen, Thamar B van Dijk, et al.
The Lancet. Haematology|June 25, 2021
Perioperative pharmacokinetic-guided factor VIII concentrate dosing in haemophilia (OPTI-CLOT trial): an open-label, multicentre, randomised, controlled trialIris van Moort, Tim Preijers, Laura H Bukkems, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 10, 2017
Emergency department blood alcohol level associates with injury factors and six-month outcome after uncomplicated mild traumatic brain injuryJohn K Yue, Laura B Ngwenya, Pavan S Upadhyayula, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 12, 2024
Peri-operative desmopressin combined with pharmacokinetic-guided factor VIII concentrate in non-severe haemophilia A patientsLorenzo G R Romano, Lisette M Schütte, Reinier M van Hest, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 27, 2025
Current Practice Regarding Bleeding Disorders of Unknown Cause in the Netherlands: A National SurveyCaroline M A Mussert, Amaury L L Monard, Tirsa T van Duijl, et al.
Research and Practice in Thrombosis and Haemostasis|December 17, 2024
Bleeding disorder of unknown cause: an illustrated review on current practice, knowledge gaps, and future perspectivesAmaury L L Monard, Caroline M A Mussert, Tirsa T van Duijl, et al.
Pageof 45

Showing results (411-420 of 442) with videos related to

Sort By:
Pageof 45
Hemasphere|June 26, 2024
Metabolic blood profile and response to treatment with the pyruvate kinase activator mitapivat in patients with sickle cell diseaseMyrthe J van Dijk, Titine J J Ruiter, Sigrid van der Veen, et al.
Research and Practice in Thrombosis and Haemostasis|April 25, 2024
Tachyphylaxis and reproducibility of desmopressin response in perioperative persons with nonsevere hemophilia A: implications for clinical practiceL G R Romano, L M Schütte, R M van Hest, et al.
Thrombosis and Haemostasis|June 12, 2015
The "OPTI-CLOT" trial. A randomised controlled trial on periOperative PharmacokineTIc-guided dosing of CLOTting factor concentrate in haemophilia AHendrika C A M Hazendonk, Iris van Moort, Karin Fijnvandraat, et al.
Clinical and Translational Radiation Oncology|April 21, 2026
Outcomes after (chemo)radiotherapy for anal cancer - A nationwide cohort studyC L Deijen, M Berbée, E D Geijsen, et al.
Blood Advances|May 3, 2021
Molecular analysis of the erythroid phenotype of a patient with BCL11A haploinsufficiencyMarja W Wessels, Marjon H Cnossen, Thamar B van Dijk, et al.
The Lancet. Haematology|June 25, 2021
Perioperative pharmacokinetic-guided factor VIII concentrate dosing in haemophilia (OPTI-CLOT trial): an open-label, multicentre, randomised, controlled trialIris van Moort, Tim Preijers, Laura H Bukkems, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 10, 2017
Emergency department blood alcohol level associates with injury factors and six-month outcome after uncomplicated mild traumatic brain injuryJohn K Yue, Laura B Ngwenya, Pavan S Upadhyayula, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 12, 2024
Peri-operative desmopressin combined with pharmacokinetic-guided factor VIII concentrate in non-severe haemophilia A patientsLorenzo G R Romano, Lisette M Schütte, Reinier M van Hest, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 27, 2025
Current Practice Regarding Bleeding Disorders of Unknown Cause in the Netherlands: A National SurveyCaroline M A Mussert, Amaury L L Monard, Tirsa T van Duijl, et al.
Research and Practice in Thrombosis and Haemostasis|December 17, 2024
Bleeding disorder of unknown cause: an illustrated review on current practice, knowledge gaps, and future perspectivesAmaury L L Monard, Caroline M A Mussert, Tirsa T van Duijl, et al.
Pageof 45